Bioavailability of Two Sustained-release Theophylline Products in Healthy Males
NCT02184247
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
22
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
anhydrous theophylline, 350 mg
DRUG:
anhydrous theophylline, 300 mg
Sponsor
Boehringer Ingelheim